0 (0%) | 10-15 12:10 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 27.56 | 1-year : | 32.19 |
Resists | First : | 23.6 | Second : | 27.56 |
Pivot price | 20.55 ![]() |
|||
Supports | First : | 19.23 | Second : | 16.54 |
MAs | MA(5) : | 20.2 ![]() |
MA(20) : | 20.5 ![]() |
MA(100) : | 15.74 ![]() |
MA(250) : | 15.56 ![]() |
|
MACD | MACD : | 0.6 ![]() |
Signal : | 0.7 ![]() |
%K %D | K(14,3) : | 50.6 ![]() |
D(3) : | 36.6 ![]() |
RSI | RSI(14): 58.3 ![]() |
|||
52-week | High : | 23.6 | Low : | 8.03 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ARCT ] has closed below upper band by 26.1%. Bollinger Bands are 21.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 22.42 - 22.51 | 22.51 - 22.61 |
Low: | 18.67 - 18.75 | 18.75 - 18.84 |
Close: | 21.08 - 21.23 | 21.23 - 21.39 |
Wed, 15 Oct 2025
Arcturus Therapeutics (ARCT) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Wed, 15 Oct 2025
Technical analysis overview for ARCT stock - Portfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Wed, 15 Oct 2025
Technical analysis overview for ARCT stock - Gold Moves & Daily Profit Focused Stock Screening - newser.com
Wed, 15 Oct 2025
Analyzing ARCT with multi timeframe charts - Rate Cut & High Accuracy Trade Signal Alerts - newser.com
Fri, 10 Oct 2025
Arcturus Therapeutics (ARCT) Anticipated to Benefit from Upcomin - GuruFocus
Mon, 29 Sep 2025
$ARCT stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 27 (M) |
Shares Float | 25 (M) |
Held by Insiders | 7.8 (%) |
Held by Institutions | 89.2 (%) |
Shares Short | 5,140 (K) |
Shares Short P.Month | 5,410 (K) |
EPS | -2.23 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 8.51 |
Profit Margin | -49.3 % |
Operating Margin | -41.1 % |
Return on Assets (ttm) | -13 % |
Return on Equity (ttm) | -24.6 % |
Qtrly Rev. Growth | -43.3 % |
Gross Profit (p.s.) | -2.62 |
Sales Per Share | 4.49 |
EBITDA (p.s.) | -2.56 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -65 (M) |
Levered Free Cash Flow | -48 (M) |
PE Ratio | -9.8 |
PEG Ratio | 0 |
Price to Book value | 2.55 |
Price to Sales | 4.83 |
Price to Cash Flow | -9.1 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |